Genprex (GNPX) Stock Chart & Stock Price History → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free GNPX Stock Alerts $2.13 -0.09 (-4.05%) (As of 04/19/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Genprex Stock Price Performance5 Day Performance-17.54%1 Month Performance-34.62%3 Month Performance-73.56%6 Month Performance-82.12%Year-To-Date Performance-75.98%1 Year Performance-94.42% Receive GNPX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genprex and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> GNPX Stock Chart for Friday, April, 19, 2024 GNPX Chart by TradingView Genprex Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2024$2.21$2.21$2.27$2.1817,491 shs$4.22 million04/17/2024$2.31$2.21-4.33%$2.54$2.2020,532 shs$4.22 million04/16/2024$2.40$2.31-3.75%$2.43$2.2720,368 shs$4.41 million04/15/2024$2.68$2.40-10.45%$2.77$2.3532,879 shs$4.58 million04/12/2024$2.78$2.73-1.80%$2.87$2.6520,589 shs$5.21 million04/11/2024$2.89$2.78-3.81%$2.90$2.7416,296 shs$5.31 million Get the Latest News and Ratings for GNPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genprex and its competitors with MarketBeat's FREE daily newsletter. 04/10/2024$3.07$2.89-5.86%$3.03$2.7549,640 shs$5.52 million04/09/2024$2.96$3.07+3.72%$3.23$2.91125,926 shs$5.86 million04/08/2024$3.00$2.96-1.33%$3.24$2.9421,410 shs$5.65 million04/05/2024$2.99$3.00+0.33%$3.18$2.9717,582 shs$5.73 million04/04/2024$3.11$2.99-3.86%$3.18$2.9644,371 shs$4.46 million04/03/2024$2.84$3.11+9.51%$3.27$2.8996,389 shs$4.63 million04/02/2024$2.97$2.84-4.38%$3.00$2.7256,346 shs$4.23 million04/01/2024$2.98$2.97-0.34%$3.00$2.8447,122 shs$4.41 million03/29/2024$2.98$2.98$3.02$2.7330,047 shs$4.44 million03/28/2024$2.73$2.98+9.16%$3.02$2.7329,955 shs$4.44 million03/27/2024$2.74$2.73-0.36%$2.90$2.5150,308 shs$4.07 million03/26/2024$3.00$2.74-8.67%$3.01$2.7056,352 shs$4.08 million03/25/2024$3.06$3.00-1.96%$3.27$2.9376,172 shs$4.47 million03/22/2024$3.02$3.06+1.32%$3.08$2.9325,882 shs$4.56 million03/21/2024$2.98$3.02+1.34%$3.15$2.9341,514 shs$4.49 million03/20/2024$3.38$2.98-11.83%$3.34$2.80101,782 shs$4.44 million03/19/2024$4.09$3.38-17.36%$3.99$3.23203,487 shs$5.04 million03/18/2024$4.04$4.09+1.24%$4.48$4.0054,305 shs$6.09 million03/15/2024$4.16$4.04-2.88%$4.28$4.0337,773 shs$6.02 million03/14/2024$4.19$4.16-0.72%$4.25$4.0333,874 shs$6.20 million03/13/2024$4.21$4.19-0.48%$4.35$4.0252,999 shs$6.24 million03/12/2024$4.70$4.21-10.43%$4.63$4.17115,903 shs$6.27 million03/11/2024$4.23$4.70+11.11%$5.05$4.23292,586 shs$7.00 million03/08/2024$4.25$4.25$4.43$4.0638,274 shs$6.33 million03/07/2024$4.38$4.25-2.97%$4.34$4.0462,666 shs$6.32 million03/06/2024$4.12$4.38+6.31%$5.41$4.31438,500 shs$6.53 million03/05/2024$4.20$4.12-1.90%$4.25$3.9134,800 shs$6.14 million03/04/2024$4.48$4.20-6.25%$4.66$4.2033,628 shs$6.26 million03/01/2024$4.30$4.48+4.19%$4.65$4.2878,315 shs$6.68 million02/29/2024$4.20$4.30+2.38%$4.38$4.0826,181 shs$6.41 million02/28/2024$4.24$4.20-0.94%$4.25$4.1115,917 shs$6.26 million02/27/2024$4.48$4.24-5.36%$4.48$4.2012,237 shs$6.32 million02/26/2024$4.36$4.48+2.75%$4.48$4.2111,081 shs$6.68 million02/23/2024$4.40$4.36-0.91%$4.40$4.2211,853 shs$6.50 millionTiny Biotech Stock Wins $75 Billion Patent (Ad)A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>>02/22/2024$4.49$4.40-2.00%$4.59$4.3415,309 shs$6.54 million02/21/2024$4.29$4.49+4.66%$4.60$4.1033,194 shs$6.69 million02/20/2024$4.40$4.29-2.50%$4.38$4.0125,524 shs$6.39 million02/19/2024$4.40$4.40$4.42$4.1326,400 shs$6.56 million02/16/2024$4.38$4.40+0.46%$4.42$4.1326,430 shs$6.56 million02/15/2024$4.65$4.38-5.81%$4.60$4.3841,331 shs$6.53 million02/14/2024$4.87$4.65-4.52%$4.99$4.5243,583 shs$6.93 million02/13/2024$4.90$4.87-0.61%$4.87$4.6125,313 shs$7.26 million02/12/2024$4.58$4.90+6.99%$4.96$4.3778,445 shs$7.30 million02/09/2024$4.44$4.58+3.15%$4.70$4.07122,759 shs$6.82 million02/08/2024$5.33$4.44-16.70%$5.29$4.35163,022 shs$6.62 million02/07/2024$6.00$5.33-11.17%$5.80$5.32132,214 shs$7.92 million02/06/2024$6.70$6.00-10.45%$6.49$5.90135,818 shs$8.94 million02/05/2024$5.91$6.70+13.37%$7.99$5.461.57 million shs$9.98 million02/02/2024$7.34$5.91-19.48%$6.44$5.15159,781 shs$351.29 million02/01/2024$7.60$7.34-3.42%$8.40$7.3053,324 shs$10.91 million01/31/2024$10.72$7.60-29.10%$9.26$7.6088,096 shs$11.29 million01/30/2024$10.84$10.72-1.11%$12.11$9.4074,958 shs$15.93 million01/29/2024$9.32$10.84+16.31%$13.00$9.20113,883 shs$16.11 million01/26/2024$9.11$9.32+2.28%$9.52$8.812,700 shs$13.85 million01/25/2024$9.32$9.11-2.23%$9.20$8.804,318 shs$13.54 million01/24/2024$9.11$9.32+2.33%$9.52$9.088,014 shs$13.85 million01/23/2024$8.61$9.11+5.81%$9.41$8.208,333 shs$13.53 million01/22/2024$8.36$8.61+2.97%$8.88$8.204,303 shs$12.79 million01/19/2024$8.26$8.36+1.16%$8.80$8.003,071 shs$12.42 million01/18/2024$8.54$8.26-3.19%$8.60$8.003,963 shs$12.28 million Related Companies: GTBP Stock Chart ENSC Stock Chart SONN Stock Chart OGEN Stock Chart DRUG Stock Chart HOTH Stock Chart ALZN Stock Chart ZVSA Stock Chart LGVN Stock Chart ATXI Stock Chart Receive GNPX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genprex and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GNPX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlace1970’s computer coder issues shocking A.I. warningTradeSmithHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genprex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.